Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Trial of Intravenous Immune Globulin in Dermatomyositis.

< BACK TO ARCHIVE


Papers: 1 Oct 2022 - 7 Oct 2022

PAIN TYPE:
Itch


2022 Oct 06


N Engl J Med


http://www.ncbi.nlm.nih.gov/pubmed/36198179?dopt=Abstract


387


14

Trial of Intravenous Immune Globulin in Dermatomyositis.

Authors

Trial of Intravenous Immune Globulin in Dermatomyositis.
Aggarwal R, Charles-Schoeman C, Schessl J, Bata-Csörgő Z, Dimachkie MM, Griger Z, Moiseev S, Oddis C, Schiopu E, Vencovský J, Beckmann I, Clodi E, Bugrova O, Dankó K, Ernste F, Goyal NA, Heuer M, Hudson M, Hussain YM, Karam C, et al.
N Engl J Med. 2022 Oct 06; 387(14):1264-1278.
PMID: 36198179.

Abstract

Intravenous immune globulin (IVIG) for the treatment of dermatomyositis has not been extensively evaluated.
Read This Paper